Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.62 |
| ▸ | HTR1D | P28221 | 2/20 | 0.60 |
| ▸ | HTR1B | P28222 | 2/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.51 |
| ▸ | HTR1A | P08908 | 2/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | DRD1 | P21728 | 1/20 | 0.51 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12129219 | 0.98 | HTR1D (0.61) | PTGDR2HTR1DHTR1BCHRM1HTR1A | |
| SCHEMBL5669748 | 0.83 | SLC6A2 (0.68) | HTR1ASLC6A2SLC6A4HTR2CSLC6A3 | |
| SCHEMBL10632447 | 0.82 | PTGDR2 (0.62) | PTGDR2HTR1DHTR1BCHRM1HTR1A | |
| SCHEMBL24893446 | 0.81 | ADRA2A (0.58) | PTGDR2HTR1DHTR1BCHRM1HTR1A | |
| SCHEMBL11127696 | 0.81 | PTGDR2 (0.60) | PTGDR2HTR1DHTR1BCHRM1HTR1A | |
| SCHEMBL15473204 | 0.81 | HTR1D (0.67) | PTGDR2HTR1DHTR1BCHRM1HTR1A | |
| SCHEMBL9810931 | 0.80 | HTR1D (0.48) | PTGDR2HTR1DHTR1BCHRM1HTR1A | |
| SCHEMBL19036960 | 0.80 | ALDH1A1 (0.47) | PTGDR2HTR1DHTR1BSLC6A4ALDH1A1 | |
| SCHEMBL10632525 | 0.80 | PTGDR2 (0.59) | PTGDR2HTR1DHTR1BCHRM1HTR1A | |
| SCHEMBL4736528 | 0.79 | HTR2C (0.68) | PTGDR2HTR1DHTR1BADRA2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140227201-A1 | Antimicrobial Gel Formulations | NOVABAY PHARMACEUTICALS, INC. | 2014-08-14 | — | — | US | claimed |
| JP-2012500209-A | — | — | 2012-01-05 | — | — | JP | claimed |
| EP-2312939-A1 | ANTIMICROBIAL GEL FORMULATIONS | NovaBay Pharmaceuticals, Inc. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100076089-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. | 2010-03-25 | — | — | US | claimed |
| WO-2010019723-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2010-02-18 | — | — | WO | claimed |
| US-20030139312-A1 | Highly concentrated fabric softener compositions and articles containing such compositions | PROCTER & GAMBLE COMPANY, THE | 2003-07-24 | — | — | US | claimed |
| US-20030104969-A1 | Laundry system having unitized dosing | PROCTER & GAMBLE COMPANY,THE | 2003-06-05 | — | — | US | claimed |
| EP-1297101-A2 | LAUNDRY SYSTEM HAVING UNITIZED DOSING | THE PROCTER & GAMBLE COMPANY (US) | 2003-04-02 | — | — | EP | claimed |
| EP-1280882-A1 | HIGHLY CONCENTRATED FABRIC SOFTENER COMPOSITIONS AND ARTICLES CONTAINING SUCH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2003-02-05 | — | — | EP | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2001085892-A1 | HIGHLY CONCENTRATED FABRIC SOFTENER COMPOSITIONS AND ARTICLES CONTAINING SUCH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-15 | — | — | WO | claimed |
| WO-2001085888-A2 | LAUNDRY SYSTEM HAVING UNITIZED DOSING | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-15 | — | — | WO | claimed |
| EP-1021511-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | Bush Boake Allen Inc. (US) | 2000-07-26 | — | — | EP | claimed |
| US-5972864-A | BLEACHING BLOCK; MIXTURE OF BLEACH AND ORGANOLEPTIC COMPOUND | LONZA INC. (US) | 1999-10-26 | — | — | US | claimed |
| US-5942153-A | A SHAPED STABLE BLOCK COMPRISING AN ORGANOLEPTIC FRAGRANT AGENT AND BLEACHING AGENT; FRAGRANT AGENT DOES NOT DECOMPOSE THE BLEACHING AGENT, NOT HYGROSCOPIC; USE IN VENTILATING HOOD AS PROTECTIVE GLOVES, A DUST MASK, AND GOGGLES | BUSH BOAKE ALLEN INC. (US) | 1999-08-24 | — | — | US | claimed |
| WO-1998006804-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | BUSH BOAKE ALLEN INC. (US) | 1998-02-19 | — | — | WO | claimed |
| US-12104145-B2 | Laundry scent additive | THE PROCTER & GAMBLE COMPANY (US) | 2024-10-01 | — | — | US | disclosed |
| US-12104146-B2 | Laundry scent additive | THE PROCTER & GAMBLE COMPANY (US) | 2024-10-01 | — | — | US | disclosed |
| WO-1998006804-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | BUSH BOAKE ALLEN INC. (US) | 1998-02-19 | — | — | WO | disclosed |
| CN-1117515-A | Liquid crystalline compound, liquid crystal composition and liquid crystal display element | CHISSO CORP (JP) | 1996-02-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140227201-A1 | Antimicrobial Gel Formulations | CUTA, TUBA3C, POLR1C | PTGDR2 3167/4885HTR1D 2605/4885HTR1B 3973/4885 |
| US-20100076089-A1 | ANTIMICROBIAL GEL FORMULATIONS | CUTA, TUBA3C, POLR1C | PTGDR2 3167/4885HTR1D 2605/4885HTR1B 3973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.